A 20-year-old male presents in the emergency room with a lymphoma involving the mediastinum that is producing respiratory distress. The lymphocytes are most likely to have cell surface markers characteristic of which of the following?
First, I need to recall the types of lymphomas. The main categories are Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL). HL is more common in young adults and often presents with mediastinal involvement. NHL can also be in young people but maybe less frequently in the mediastinum.
HL is characterized by Reed-Sternberg cells, which are CD30 positive. NHL has various subtypes; for example, B-cell lymphomas like diffuse large B-cell lymphoma (DLBCL) might have CD20 markers. But since the question mentions lymphocytes, maybe it's referring to the neoplastic cells. But Reed-Sternberg cells are not lymphocytes; they are derived from B cells but have a different marker profile.
Wait, but HL is considered a lymphoma where the malignant cells are Reed-Sternberg cells, which are CD30+ and CD15+. NHLs can be B-cell or T-cell origins. If the lymphoma is in the mediastinum, HL is a common cause. So the cell surface markers would be CD30 and CD15.
Looking at the options, the correct answer is likely CD30 and CD15. Let me check the options again. The user didn't list the options, but the correct answer is probably CD30 and CD15. The distractors might include CD20 (B-cell marker), CD3 (T-cell), CD8 (T-cell), or others.
The core concept here is distinguishing HL from NHL based on cell surface markers. HL's Reed-Sternberg cells are CD30+ and CD15+, whereas NHLs have different markers depending on the type. So the correct answer would be CD30 and CD15. The other options would be markers for other lymphomas.
Wait, but the question says "lymphocytes are most likely to have cell surface markers." Reed-Sternberg cells are not lymphocytes; they are large, multinucleated cells. However, HL is a lymphoma where the Reed-Sternberg cells are the malignant cells. The background may have reactive lymphocytes. But the question is about the lymphoma cells, which are Reed-Sternberg cells. So the cell surface markers would be CD30 and CD15.
Therefore, the correct answer is CD30 and CD15. The other options would be markers for B-cell or T-cell lymphomas. For example, CD20 is a B-cell marker, CD3 for T-cells, CD8 for cytotoxic T-cells. So if the options included CD30 and CD15, that's the right choice.
**Core Concept:** This question assesses the differentiation between Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) based on cell surface markers. HL is characterized by Reed-Sternberg cells expressing CD30 and CD15, while NHL subtypes (e.g., B-cell or T-cell lymphomas) have distinct markers like CD20, CD3, or CD8.
**Why the Correct Answer is Right:**